Sara Frank
Nurse Practitioner · Baton Rouge, LANPI 1144569104
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,700 of the $13,588 with a category attached, or 64.0%. Amgen accounts for 70.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $10,618 and has fallen 99.8% since, to $24 in 2025. Among nurse practitioner clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $47.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$10K
- Johnson & Johnson$748
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$496
- Merck$354
- Pfizer$338
- Irhythm Technologies, Inc.$259
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$8,70064%
- Travel & lodging$1771%
- Food & beverage$4,67234%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 43 | $9,629 |
| Johnson & Johnson | 55 | $748 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 31 | $496 |
| Merck | 23 | $354 |
| Pfizer | 20 | $338 |
| Irhythm Technologies, Inc. | 17 | $259 |
| Boehringer Ingelheim | 12 | $250 |
| Esperion Therapeutics, Inc. | 13 | $234 |
| Novartis | 18 | $214 |
| AstraZeneca | 10 | $133 |
| E.r. Squibb & Sons, L.L.C. | 6 | $103 |
| Kestra Medical Technology Services, Inc. | 4 | $101 |
| Arbor Pharmaceuticals, Inc. | 5 | $86 |
| Impulse Dynamics (USA) Inc. | 3 | $80 |
| Bayer | 5 | $80 |
| Cvrx, Inc. | 2 | $67 |
| Abbott | 2 | $65 |
| Novo Nordisk | 3 | $62 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Amarin Pharma, Inc. | 3 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $36 |
| Vifor Pharma, Inc. | 2 | $30 |
| Biotronik Inc. | 2 | $30 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$9,053
How this compares
$13,588 in reported general payments places this provider in the 95th percentile of 969 nurse practitioner providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 175 | $160,260 |
| EntrestoSacubitril/Valsartan | 112 | $104,542 |
| XareltoRivaroxaban | 76 | $54,434 |
| Repatha SureclickEvolocumab | 28 | $25,701 |
| JardianceEmpagliflozin | 11 | $9,750 |
| BrilintaTicagrelor | 14 | $7,104 |
| Metoprolol Succinate | 227 | $2,821 |
| Ranolazine ErRanolazine | 22 | $1,406 |
| Valsartan | 30 | $1,335 |
| Rosuvastatin Calcium | 111 | $1,243 |
| ClopidogrelClopidogrel Bisulfate | 74 | $752 |
| Nebivolol Hcl | 23 | $751 |
| Flecainide Acetate | 23 | $635 |
| Doxazosin Mesylate | 25 | $579 |
| Carvedilol | 66 | $529 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $338 | $160,260175 claims |
| NovartisEntresto | $214 | $104,542112 claims |
| Johnson & JohnsonXarelto | $748 | $54,43476 claims |
| Boehringer IngelheimJardiance | $250 | $9,75011 claims |
| AstraZenecaBrilinta | $133 | $7,10414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 969 nurse practitioner providers in Louisiana.
Other nurse practitioner in Baton Rouge
- Jasmine SpearmanBaton Rouge$13K
- Morgan HoffmanBaton Rouge$12K
- Breanna ByrdBaton Rouge$9K
- Ashley AmedeeBaton Rouge$9K
- Judson JonesBaton Rouge$9K
- Emily Santa AnaBaton Rouge$7K
- Allyson DupreBaton Rouge$7K
- Karen DeshotelLafayette$264K
- Christopher ManuelKaplan$145K
- Tammy BennettShreveport$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.